Updated:
NavaDerm Partners
NavaDerm Partners is a asset manager based in New York; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts for...
NavaDerm Partners
Northeast-based dermatology platform formed through the recapitalization of four dermatology groups in New York and New Jersey.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Roy Geronemus
Partner (physician lead)
Sapna Palep
Partner (physician lead)
Sector focus
Frequently asked questions
Who runs investment decisions at NavaDerm Partners?
Investment oversight appears to rest with the physician partners—Dr. Roy Geronemus and Dr. Sapna Palep—who lead the New York and Manhattan groups respectively (per firm website). The firm does not list a separate CIO or financial manager on its public materials.
How does NavaDerm source proprietary deal flow?
NavaDerm's formation involved recapitalizing existing dermatology groups in the Northeast. The firm likely sources new partners through practitioner networks and professional referrals, given its physician-led structure.
Is NavaDerm structured as a single family office or does it operate more like a venture firm?
NavaDerm Partners is best described as a services platform or operating company, not a family office or a traditional asset manager. It consolidates dermatology practices into a single entity but does not manage third-party capital or report an investment fund.
Does NavaDerm participate in fund commitments or only direct deals?
NavaDerm does not appear to make external fund commitments. Its activity is limited to operating dermatology practices directly.
What investment stages does NavaDerm typically target?
NavaDerm targets mature dermatology groups seeking consolidation. The firm does not engage in early-stage venture or start-up practices.
Which sectors does NavaDerm explicitly avoid?
The firm operates exclusively in dermatology. It has no disclosed exposure to other healthcare segments, such as primary care or dental, nor to non-healthcare sectors.
How is NavaDerm related to the sponsoring investor?
The firm's website does not name the recapitalization partner. The ownership structure beyond the physician partners is not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: